Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049888 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL52706 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049893 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049856 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL318062 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL24597734 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL3862786 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL47126 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL1703446 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049851 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619922-A | Hydroxamic acid compound, and preparation method and application thereof | 郑州大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118546075-A | Isosteviol and steviol derivative containing hydroxamic acid groups as well as preparation method and application thereof | 新乡医学院 | 2024-08-27 | — | — | CN | claimed |
| CN-118221674-A | Pyrrolo [3,2-b ] pyridine Top/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof | 南京市鸿舜医药科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-115850618-A | Dynamic cross-linked azobenzene liquid crystal elastomer with linear/star SBS block copolymer as main chain and preparation method thereof | 大连理工大学 | 2023-03-28 | — | — | CN | claimed |
| CN-110484366-A | A kind of quick-fried pearl fennel essence and preparation method thereof, quick-fried pearl and cigarette | CHINA TOBACCO HENAN IND CO LTD | 2019-11-22 | — | — | CN | claimed |
| US-20260092057-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20250296929-A1 | NOVEL HEPATOSELECTIVE POLYADENYLATING POLYMERASES INHIBITORS AND THEIR METHOD OF USE | BARUCH S. BLUMBERG INSTITUTE | 2025-09-25 | — | — | US | disclosed |
| EP-4598536-A2 | INDAZOLE PYRIDONE COMPOUNDS AND USES THEREOF | Bluejay Therapeutics, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250197387-A1 | BCL-XL DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-06-19 | — | — | US | disclosed |
| CN-120051281-A | Indazole pyridone compounds and uses thereof | 蓝樫鸟医药公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-120040359-A | Azole selenourea carboxylate and preparation method and application thereof | 华南农业大学 | 2025-05-27 | — | — | CN | disclosed |
| US-20250145607-A1 | Modulators of CAMKK2 as Ligand Directed Degraders | CELGENE CORPORATION (US) | 2025-05-08 | — | — | US | disclosed |
| WO-2005121904-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121204-A2 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| EP-0626969-B1 | CoA-IT AND PAF INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2000-05-24 | — | — | EP | disclosed |
| US-5663053-A | COENZYME A TRANSACYLASE FOR SCREENING | SMITHKLINE BEECHAM CORPORATION (US) | 1997-09-02 | — | — | US | disclosed |
| US-5648373-A | CoA-IT and PAF inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-15 | — | — | US | disclosed |
| EP-0626969-A4 | CoA-IT AND PAF INHIBITORS. | SMITHKLINE BEECHAM CORP (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0626969-A1 | CoA-IT AND PAF INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016674-A1 | CoA-IT AND PAF INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296929-A1 | NOVEL HEPATOSELECTIVE POLYADENYLATING POLYMERASES INHIBITORS AND THEIR METHOD OF USE | RNASE1, PAPSS1, PABPC1 | CYP1A2 1664/4885ALDH1A1 1091/4885TRPA1 4875/4885 |
| US-20250145607-A1 | Modulators of CAMKK2 as Ligand Directed Degraders | CAMKK2, CAMKK1, CAMK1D | CYP1A2 462/4885ALDH1A1 1846/4885TRPA1 3960/4885 |
| US-20250197387-A1 | BCL-XL DEGRADERS AND USES THEREOF | XIAP, BCL2L1, BCL2L10 | CYP1A2 4634/4885ALDH1A1 4101/4885TRPA1 4800/4885 |
| US-20260092057-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | BCL2L2, BCL2A1, BCL2L1 | CYP1A2 708/4885ALDH1A1 1304/4885TRPA1 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.